AVITA Medical Inc [RCEL] stock prices are up 20.39% to $10.57 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The RCEL shares have gain 21.77% over the last week, with a monthly amount glided 18.50%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
AVITA Medical Inc [NASDAQ: RCEL] stock has seen the most recent analyst activity on December 24, 2024, when D. Boral Capital initiated its Buy rating and assigned the stock a price target of $25. Previously, BTIG Research downgraded its rating to Neutral on April 11, 2024. On June 27, 2023, Cantor Fitzgerald initiated with a Overweight rating and assigned a price target of $23 on the stock. Piper Sandler started tracking the stock assigning a Overweight rating and suggested a price target of $27 on March 02, 2021. BofA Securities initiated its recommendation with a Buy and recommended $42 as its price target on August 27, 2020. Oppenheimer started tracking with a Outperform rating for this stock on April 21, 2020, and assigned it a price target of $9. In a note dated March 03, 2020, BTIG Research initiated an Buy rating and provided a target price of $10 on this stock.
The stock price of AVITA Medical Inc [RCEL] has been fluctuating between $7.51 and $18.93 over the past year. Currently, Wall Street analysts expect the stock to reach $14 within the next 12 months. AVITA Medical Inc [NASDAQ: RCEL] shares were valued at $10.57 at the most recent close of the market. An investor can expect a potential return of 32.45% based on the average RCEL price forecast.
Analyzing the RCEL fundamentals
The AVITA Medical Inc [NASDAQ:RCEL] reported sales of 64.25M for trailing twelve months, representing a surge of 29.67%. Gross Profit Margin for this corporation currently stands at 0.82% with Operating Profit Margin at -0.8%, Pretax Profit Margin comes in at -0.77%, and Net Profit Margin reading is -0.77%. To continue investigating profitability, this company’s Return on Assets is posted at -0.27, Equity is -0.4 and Total Capital is -0.31. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 9.76 points at the first support level, and at 8.96 for the second support level. However, for the 1st resistance point, the stock is sitting at 11.31, and for the 2nd resistance point, it is at 12.06.
Ratios To Look Out For
It’s worth pointing out that AVITA Medical Inc [NASDAQ:RCEL]’s Current Ratio is 2.83. In addition, the Quick Ratio stands at 2.47 and the Cash Ratio stands at 1.7. Considering the valuation of this stock, the price to sales ratio is 4.09, the price to book ratio is 61.92.
Transactions by insiders
Recent insider trading involved Crowe Suzanne, Director, that happened on Dec 09 ’24 when 486.0 shares were purchased. CFO, O’Toole David D completed a deal on Dec 05 ’24 to buy 975.0 shares. Meanwhile, CFO O’Toole David D bought 1000.0 shares on May 30 ’24.
